Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

Wacker Chemie A.G. has opened an expanded, "double-digit millions of dollars" facility for biotechnology research in food and ...

The Wacker Biotechnology Center is in Munich, where the company has been conducting fundamental research for over a century.

Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids (BEV-SNAs), which has shown efficacy in treating idiopathic pulmonary fibrosis ...

Microplate fluorometers are indispensable tools across a wide range of disciplines, including molecular biology, pharmaceutical research, environmental monitoring, and the food and cosmetics ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that it has received a delisting notification from The Nasdaq Stock Market ...

BrainStorm to Continue with Planned Phase 3b Trial and Remains Committed to Advancing Access for People Living with ALS NEW YORK, July 8, 2025 /PRNewswire/ -- BrainStorm ...

The 2025 CSAR Student Award winners were presented with their certificates by Dr Diarmuid O’Brien, the University of ...

Shenzhou-20 taikonauts who are currently staying and working in the orbiting China Tiangong Space Station have opened the ...

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...

Wacker Chemie has invested a double-digit million-euro amount in the new Wacker Biotechnology Center which is located in ...

Wacker Chemie AG (Munich, Germany) has opened the Wacker Biotechnology Center in Munich. Eminent politicians and guests from ...